New tools to help understand infectious bursal disease virus variants developed by Pirbright researchers
Posted: 12 January, 2023
Researchers at The Pirbright Institute have developed new tools and techniques to determine the breadth of immune responses produced by vaccines against different variants of infectious bursal disease virus (IBDV).
IBDV is a major threat to the productivity of the global commercial poultry industry. The virus not only causes severe disease but also suppresses the immune response of birds, leading to increased susceptibility to other infections.
